About us

Founded in 2001, Linguamatics is the world-leader in deploying innovative natural language processing (NLP)-based text mining for high-value knowledge discovery and decision support. We aim to produce software and solutions to help the pharma-biotech and healthcare industries speed up the drug-discovery cycle and improve patient outcomes.

In 2014, due to our success, we won the Queen's Award for Enterprise in International Trade. We were also honored to be recognized by Frost & Sullivan for Best Practices Awards in 2016 for Market Leadership and in 2017 for Healthcare Enabling Technology Leadership.

The executive team

Our executive team has a wealth of complementary skills and experience in world-class research and business development, both in academia and leading-edge science and technology companies.

more

Linguamatics' customers include 18 of the top 20 global pharmaceutical companies

Our customers

Customers include 18 of the top 20 global pharmaceutical companies; the US Food and Drug Administration (FDA); and leading cancer institutes, hospitals and academic research centres. I2E has been deployed by organizations in pharmaceuticals, biotechnology, healthcare, chemicals and agrochemicals, Government and academia.

MORE

Linguamatics partners with global informatics software providers such ChemAxon, Biovia and Knime

Partners

We partner and collaborate with companies, academic and governmental organizations to bring customers the right solution for their needs, and to develop next generation capabilities. To find out more about current collaborations, click below.

More

Work for us

People are the reason why Linguamatics has been so successful and we make a significant investment in finding and retaining the right people. If you think you can make a difference, we'd like to hear from you.

More